Detailed Notes on 줄기세포 지방이식
Chimeric antigen receptor (Vehicle) therapy targeting CD19 has yielded extraordinary results in sufferers with acute lymphoblastic leukemia. To recognize possible Vehicle targets in acute myeloid leukemia (AML), we probed the AML surfaceome for overexpressed molecules with tolerable systemic expression. We built-in large transcriptomics and proteom